AB Science

AB Science was founded in 2001 by a team of researchers, clinicians and entrepreneurs who have dedicated their lives to discover key mechanisms in life science and develop new drugs targeting these mechanisms to dramatically change the life of patients in the most unmet medical needs. We are innovators and scientific entrepreneurs in the field of life science. Our group is specialized in targeted therapies through tyrosine kinase inhibitors for treating diseases with high medical needs in the field of cancers, chronic inflammatory diseases and neurological degenerative disorders. We remain fully committed in meeting our objectives and we are very confident in our capacities to develop leading treatments that will dramatically change the lives of the patients.
Type
Public
HQ
Paris, FR
Founded
2001
Size (employees)
136 (est)-6%
AB Science was founded in 2001 and is headquartered in Paris, FR

AB Science Office Locations

AB Science has offices in Paris and Chatham
Paris, FR (HQ)
3 Avenue George V
Chatham, US
39 Main St

AB Science Financials and Metrics

AB Science Financials

EUR

Market capitalization (31-Oct-2017)

370.6 m

Closing share price (31-Oct-2017)

8.8
AB Science's current market capitalization is €370.6 m.
Show all financial metrics

AB Science Market Value History

AB Science's Web-traffic and Trends

AB Science Company Life and Culture

You may also be interested in